This bidirectional modulation gives the compound a homeostatic quality: it pushes tissue toward repair rather than simply amplifying any single pathway
Sauder HM et al
REDEFINE 1 Results (Phase 3) The landmark trial randomized 3,417 adults to CagriSema 2.4/2.4 mg, semaglutide 2.4 mg alone, cagrilintide 2.4 mg alone, or placebo for 68 weeks (Aronne et al., 2025): The combination significantly outperformed either component alone
The mechanism is plausible: dopamine D2 receptor modulation and serotonergic interactions can shift the neurotransmitter balance toward wakefulness
Endothelial function The inner lining of blood vessels, known as the vascular endothelium, plays an important role in the maintenance of cardiovascular health
Other Ingredients: Microcrystalline Cellulose, Time-Released VegiCap Manufactured for and distributed by: Integrative Peptides, LLC